www.fdanews.com/articles/113597-us-fda-backs-merck-schering-plough-8217-s-vytorin
US FDA Backs Merck, Schering-Plough’s Vytorin
January 9, 2009
A U.S. regulatory review of the controversial cholesterol drug Vytorin, made by Merck & Co Inc and Schering-Plough Corp, found the drug works and should still be used, but the positive finding may be too late to win back patients.
guardian.co.uk
guardian.co.uk